ALArturo M. Lichauco

Arturo M. Lichauco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arturo M. Lichauco has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Off‐the‐Shelf Synthetic Biodegradable Grafts Transform In Situ into a Living Arteriovenous Fistula in a Large Animal Model

    by Paul J. Besseling, Wojciech Szymczyk, Martin Teraa, Raechel J. Toorop, Dan Jing Wu, Rob C. H. Driessen, Arturo M. Lichauco, Henk M. Janssen, Melanie van de Kaa, Krista Den Ouden, et al.

    Current vascular access options require frequent interventions. In situ tissue engineering (TE) may overcome these limitations by combining the initial success of synthetic grafts with long‐term advantages of autologous vessels by using biodegradable grafts that transform into autologous vascular tissue at the site of implantation. Scaffolds (6 mm‐Ø) made of supramolecular polycarbonate‐bisurea (PC‐BU), with a polycaprolactone (PCL) anti‐kinking‐coil, are implanted between the carotid artery and jugular vein in goats. A subset is bio‐functionalized using bisurea‐modified‐Stromal cell‐derived factor‐1α (SDF1α) derived peptides and ePTFE grafts as controls. Grafts are explanted after 1 and 3 months, and evaluated for material degradation, tissue formation, compliance, and patency. At 3 months, the scaffold is resorbed and replaced by vascular neo‐tissue, including elastin, contractile markers, and endothelial lining. No dilations, ruptures, or aneurysms are observed and grafts are successfully cannulated at termination. SDF‐1α‐peptide‐biofunctionalization does not influence outcomes. Patency is lower in TE grafts (50%) compared to controls (100% patency), predominantly caused by intimal hyperplasia. Rapid remodeling of a synthetic, biodegradable vascular scaffold into a living, compliant arteriovenous fistula is demonstrated in a large animal model. Despite lower patency compared to ePTFE, transformation into autologous and compliant living tissue with self‐healing capacity may have long‐term advantages.


  • Open Access

    Inflammatory and regenerative processes in bioresorbable synthetic pulmonary valves up to two years in sheep–Spatiotemporal insights augmented by Raman microspectroscopy

    by B.J. De Kort, J. Marzi, E.M. Brauchle, A.M. Lichauco, H.S. Bauer, A. Serrero, S. Dekker, M.A.J. Cox, F.J. Schoen, K. Schenke-Layland, et al.